Prognostic performance of serum YKL-40 for one-year clinical outcomes in acute ischemic stroke.
Aging(2023)
Abstract
Elevated serum YKL-40 at admission might be independently associated with one-year poor outcome and all-cause mortality but not stroke recurrence among Chinese AIS patients.
MoreTranslated text
Key words
YKL-40,acute ischemic stroke,mortality,outcome,recurrence
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined